Testing effectiveness (Phase 2)UnknownNCT05315778What this trial is testingAnti-BCMA CAR T-Cell Therapy for R/R ITPWho this might be right forITP The First Affiliated Hospital of Soochow University 5
Testing effectiveness (Phase 2)Study completedNCT03838354What this trial is testingA Clinical Trial of Chidamide in the Management of Refractory ITPWho this might be right forThrombocytopenia Shandong University 61
Not applicableStudy completedNCT01672151What this trial is testingEfficacy of Rapamycin Therapy With Chronic Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenic Purpura First Affiliated Hospital of Suzhou Medical College 35
Testing effectiveness (Phase 2)UnknownNCT01162941What this trial is testingEfficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)Who this might be right forThrombocytopenia Cooperative Study Group A for Hematology 38
Testing effectiveness (Phase 2)Study completedNCT00102739What this trial is testingSB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP)Who this might be right forPurpura, Thrombocytopaenic, Idiopathic GlaxoSmithKline 99
Testing effectiveness (Phase 2)Study completedNCT00706342What this trial is testingPilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)Who this might be right forPurpura, Thrombocytopenic, Idiopathic Rigel Pharmaceuticals 18
Testing effectiveness (Phase 2)Looking for participantsNCT05599880What this trial is testingThe Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune ThrombocytopeniaWho this might be right forRelapsed/Refractory Immune Thrombocytopenia Seoul National University Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT06352281What this trial is testingEfficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)Who this might be right forITP - Immune Thrombocytopenia 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 10
Not applicableLooking for participantsNCT06973356What this trial is testingAnti CD19/BCMA CAR Gene Therapy for Relapsed/Refractory Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia (ITP) Anhui Provincial Hospital 18
Very early researchLooking for participantsNCT06337474What this trial is testingAn Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune ThrombocytopeniaWho this might be right forThrombocytopenia Alloimmune Changzhou No.2 People's Hospital 9
Testing effectiveness (Phase 2)UnknownNCT05562882What this trial is testingA Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Institute of Hematology & Blood Diseases Hospital, China 60
Early research (Phase 1)Study completedNCT00001630What this trial is testingTreatment of Autoimmune Thrombocytopenia (AITP)Who this might be right forAutoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia National Heart, Lung, and Blood Institute (NHLBI) 29
Early research (Phase 1)Not Yet RecruitingNCT07622329What this trial is testingA Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune ThrombocytopeniaWho this might be right forThrombocytopenic Purpura, Immune The General Hospital of Western Theater Command 4
Large-scale testing (Phase 3)Study completedNCT01525836What this trial is testingRhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITPWho this might be right forPurpuraIdiopathic Thrombocytopenic Purpura Shandong University 123
Testing effectiveness (Phase 2)Looking for participantsNCT07175493What this trial is testingCM336 in Patients With Relapsed or Refractory Autoimmune CytopeniaWho this might be right forAutoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more Keymed Biosciences Co.Ltd 158
Early research (Phase 1)Not Yet RecruitingNCT07599280What this trial is testingUniversal STAR-T Cell Injection in R/R Autoimmune Diseases.Who this might be right forImmune Thrombocytopenia Jian Zhu 6
Early research (Phase 1)Looking for participantsNCT07072247What this trial is testingRN1201 Injection in the Treatment of Antibody-Mediated DiseasesWho this might be right forRefractory Immune-mediated Platelet Transfusion RefractorinessRelapsed or Refractory Immune Thrombocytopenia The First Affiliated Hospital of Soochow University 9
Not applicableLooking for participantsNCT07206823What this trial is testingEfficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune ThrombocytopeniaWho this might be right forPrimacy Immune Thrombocytopenia The First Affiliated Hospital of Soochow University 30
Not applicableStudy completedNCT04014166What this trial is testingStudy of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune ThrombocytopeniaWho this might be right forThrombocytopeniaMesenchymal Stem Cells Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)UnknownNCT05020288What this trial is testingA Clinical Trial of the Orelabrutinib in the Management of Refractory ITPWho this might be right forImmune ThrombocytopeniaBruton's Tyrosine Kinase Shandong University 40